Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN)

CUSIP: 03815U409

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
1,384,245
Total 13F shares
754,036
Share change
-112,377
Total reported value
$486,221
Price per share
$0.65
Number of holders
18
Value change
-$28,138
Number of buys
10
Number of sells
9

Security key

03815U409

Report period

Q3 2024

Institutions

18

Top holders

10

Top shareholders of APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AMH Equity Ltd
13F
Company
47%
649,809
$265,382 30 Jun 2024
13F
Altium Capital Management LLC
13F
Company
6.2%
86,152
$35,184 30 Jun 2024
13F
SABBY MANAGEMENT, LLC
13F
Company
5.1%
70,463
$28,777 30 Jun 2024
13F
Virtu Financial LLC
13F
Company
1.4%
19,021
$8,000 30 Jun 2024
13F
Ground Swell Capital, LLC
13F
Company
1.1%
15,250
$6,228 30 Jun 2024
13F
XTX Topco Ltd
13F
Company
0.74%
10,261
$4,191 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
0.37%
5,066
$2,069 30 Jun 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.29%
4,069
$1,660 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.29%
3,975
$1,624 30 Jun 2024
13F
Nordwand Advisors, LLC
13F
Company
0.07%
1,000
$408 30 Jun 2024
13F
NATIXIS
13F
Company
0.05%
677
$276 30 Jun 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
141
$58 30 Jun 2024
13F
Activest Wealth Management
13F
Company
0.01%
101
$41 30 Jun 2024
13F
UBS Group AG
13F
Company
0.01%
76
$31 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
30
$12 30 Jun 2024
13F
FMR LLC
13F
Company
0%
25
$10 30 Jun 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
2
$1 30 Jun 2024
13F
MATHER GROUP, LLC.
13F
Company
class O/S missing
700
$287 30 Jun 2024
13F
James A. Hayward
3/4/5
Chairman, CEO and President, Director
mixed-class rows
219,167
mixed-class rows
01 Nov 2021
Sanford R. Simon
3/4/5
Director
mixed-class rows
113,588
mixed-class rows
25 Jan 2023
Scott L. Anchin
3/4/5
Director
mixed-class rows
112,649
mixed-class rows
25 Jan 2023
John Bitzer III
3/4/5
Director
mixed-class rows
31,586
mixed-class rows
01 Nov 2021

Institutional Holders of Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN) as of Q3 2024

As of 30 Sep 2024, Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 754,036 shares. The largest 10 holders included AMH Equity Ltd, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, Atria Wealth Solutions, Inc., Baader Bank Aktiengesellschaft, Tower Research Capital LLC (TRC), BlackRock, Inc., CITIGROUP INC, NATIXIS, and Belvedere Trading LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
16
Q3 2024 holders
18
Holder diff
2
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .